Boundless Bio Inc (NASDAQ:BOLD) does about 96.95K shares in volume on a normal day but saw 1373689 shares change hands in the recent trading day. The company now has a market cap of 23.95M USD. Its current market price is $1.07, marking a decrease of -2.73% compared to the previous close of $1.10. The 52 week high reached by this stock is $10.13 whilst the lowest price level in 52 weeks is $1.06.
The consensus objective for the share price is $4.00, suggesting that the stock has a potential upside of 73.25% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on June 02, 2025 when H.C. Wainwright initiated the stock to “Buy” and issued a price target of $5. Leerink Partners downgraded the stock to “Market Perform” from Outperform on May 28, 2025 at a price target of $3.
The current price level is -21.35%, -23.77%, and -54.95% away from its SMA20, SMA50, and SMA200 respectively, with the BOLD price moving above the 50-day SMA on current market day. Boundless Bio Inc (BOLD) stock is down -4.46% over the week and -25.69% over the past month. Its price is -63.10% year-to-date and -88.52% over the past year.
To reach the target analysts have set, the stock logically needs to grow 73.25 percent from here.
Outstanding shares total 22.30M with insiders holding 11.40% of the shares and institutional holders owning 70.35% of the company’s common stock. The company has a return on investment of -35.53% and return on equity of -54.06%. The beta has a value of -0.72. Price to book ratio is 0.17.
